Found 473 articles for: "atopic dermatitis"
The Study of Skin of Color in Dermatology
April 2012 | Volume 11 | Issue 4 | Editorials | 448 | Copyright © April 2012
Comparative Trial of 5% Dexpanthenol in Water-in-Oil Formulation With 1% Hydrocortisone Ointment in the Treatment of Childhood Atopic Dermatitis: A Pilot Study
March 2012 | Volume 11 | Issue 3 | Original Article | 366 | Copyright © March 2012
Background: Atopic dermatitis (AD) is a common chronic relapsing disease particularly affecting children. The emollient used for protection of skin barrier function is the standard treatment fo...
Read MoreA Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects With Recalcitrant Allergic Contact or Atopic Dermatitis
March 2012 | Volume 11 | Issue 3 | Original Article | 341 | Copyright © March 2012
Objective: Evaluate the efficacy and safety of apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, in subjects with recalcitrant moderate to severe atopic dermatitis (AD) or allergic cont...
Read MoreA Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Efficacy and Safety of Clindamycin 1.2% and Tretinoin 0.025% Combination Gel for the Treatment of Acne Rosacea Over 12 Weeks
March 2012 | Volume 11 | Issue 3 | Original Article | 333 | Copyright © March 2012
Background: Papulopustular acne rosacea is a chronic inflammatory condition which can be difficult to ...
Read MoreVitamin D Supplementation in the Treatment of Atopic Dermatitis: A Clinical Trial Study
March 2012 | Volume 11 | Issue 3 | Original Article | 327 | Copyright © March 2012
Background: The role of vitamin D in Atopic Dermatitis (AD) is ambiguous and clinical trials are needed to assess the role of vitamin D in the treatment of AD. The aim of this clinical trial st...
Read MoreCLINICAL TRIAL REVIEW
February 2012 | Volume 11 | Issue 2 | Features | 276 | Copyright © February 2012
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read MorePIPELINE PREVIEWS
February 2012 | Volume 11 | Issue 2 | Features | 274 | Copyright © February 2012
Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This department may include additional information from the...
Read MoreEfficacy and Tolerability Assessment of a Topical Formulation Containing Copper Sulfate and Hypericum perforatum on Patients With Herpes Skin Lesions: A Comparative, Randomized Controlled Trial
February 2012 | Volume 11 | Issue 2 | Original Article | 209 | Copyright © February 2012
Background: Topical Acyclovir has moderate efficacy on recurrent HSV symptoms, requiring repeat applications for several days. Topical Dynamiclear, which requires only a single dose application...
Read MoreTransepidermal Water Loss (TEWL) and Corneometry With Hydrogel Vehicle in the Treatment of Atopic Dermatitis: A Randomized, Investigator-Blind Pilot Study
February 2012 | Volume 11 | Issue 2 | Original Article | 181 | Copyright © February 2012
Disruption of the epidermal barrier, as indicated by a reduction in skin hydration and an increase in transepidermal wat...
Read MoreTruth or Fiction: Risk Factors for Childhood Atopic Dermatitis
January 2012 | Volume 11 | Issue 1 | Features | 126 | Copyright © January 2012
Atopic dermatitis is increasing in prevalence throughout the developed world, in parallel with asthma and hay fever. The reasons for the increase remain unclear. As a practical question, it is valuabl...
Read MoreClinical Trial Review
December 2011 | Volume 10 | Issue 12 | Features | 1486 | Copyright © December 2011
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read MoreTreatment of Mild-to-Moderate Chronic Hand Dermatitis With Clobetasol Propionate 0.05% EF Foam: Results From an Open-Label Study
December 2011 | Volume 10 | Issue 12 | Original Article | 1398 | Copyright © December 2011
Objective: To assess the safety and efficacy of clobetasol propionate 0.05% emulsion formulation (EF) foam in sub...
Read MoreNEWS, VIEWS & REVIEWS
Truth or Fiction: Risk Factors for Childhood Atopic DermatitisNovember 2011 | Volume 10 | Issue 11 | Features | 1337 | Copyright © November 2011
Psoriasis continues to be one of the most common and frustrating conditions that dermatologists and their patients face on a daily basis. Novel developments in basic science bring us closer than ever ...
Read MoreCLINICAL TRIAL REVIEW
October 2011 | Volume 10 | Issue 10 | Features | 1216 | Copyright © October 2011
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read MoreCutaneous Reactions to Non-steroidal Anti-inflammatory Drugs
October 2011 | Volume 10 | Issue 10 | Original Article | 1160 | Copyright © October 2011
We retrospectively reviewed the records of 195 patients with suspected cutaneous reactions from NSAIDs. Two hundred and six different non-steroidal anti-inflammatory drugs (NSAIDs) were suspected of c...
Read MoreWinning Poster: A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Contact or Atopic Dermatitis
August 2011 | Volume 10 | Issue 8 | Features | 928 | Copyright © August 2011
An Open-label Study of the Safety and Efficacy of Sertaconazole Nitrate in the Treatment of Seborrheic Dermatitis
August 2011 | Volume 10 | Issue 8 | Original Article | 895 | Copyright © August 2011
Objectives: To demonstrate the efficacy and evaluate the safety of sertaconazole nitrate cream 2% in the treatment of seborrheic dermatitis (SD).
Design: Single-center, open-label...
Read MoreA Randomized, Double-Blind, Vehicle-Controlled Crossover Study to Determine the Anti-Pruritic Efficacy, Safety and Local Dermal Tolerability of a Topical Formulation (SRD174 Cream) of the Long-Acting Opiod Antagonist Nalmefene in Subjects With Atopic Dermatitis
August 2011 | Volume 10 | Issue 8 | Original Article | 853 | Copyright © August 2011
Objective: To investigate the efficacy, safety and tolerability of topical nalmefene (SRD174), a long acting opioid antagonist for the manage...
Read MoreIncreased Prevalence of Psychiatric Disorders and Health Care-Associated Costs Among Patients With Moderate-to-Severe Psoriasis
August 2011 | Volume 10 | Issue 8 | Original Article | 843 | Copyright © August 2011
Objective: To characterize the prevalence of psychiatric disorders in patients with moderate-to-severe psoriasis and compare health care costs between patients with and without psychiatric como...
Read MorePipeline Previews
July 2011 | Volume 10 | Issue 7 | Features | 805 | Copyright © July 2011
Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This department may include additional information from th...
Read More